Fatigue among patients with renal cell carcinoma receiving adjuvant sunitinib or sorafenib: patient-reported outcomes of ECOG-ACRIN E2805 trial.
about
Fatigue among patients with renal cell carcinoma receiving adjuvant sunitinib or sorafenib: patient-reported outcomes of ECOG-ACRIN E2805 trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Fatigue among patients with re ...... mes of ECOG-ACRIN E2805 trial.
@en
Fatigue among patients with re ...... mes of ECOG-ACRIN E2805 trial.
@nl
type
label
Fatigue among patients with re ...... mes of ECOG-ACRIN E2805 trial.
@en
Fatigue among patients with re ...... mes of ECOG-ACRIN E2805 trial.
@nl
prefLabel
Fatigue among patients with re ...... mes of ECOG-ACRIN E2805 trial.
@en
Fatigue among patients with re ...... mes of ECOG-ACRIN E2805 trial.
@nl
P2093
P2860
P1476
Fatigue among patients with re ...... mes of ECOG-ACRIN E2805 trial.
@en
P2093
Fengmin Zhao
Judith Manola
Lynne I Wagner
Naomi S B Haas
Robert S DiPaola
P2860
P2888
P356
10.1007/S00520-017-4027-7
P50
P577
2017-12-23T00:00:00Z